Table 111Probability of being the most cost-effective treatment (alternative, cheaper exacerbation cost)

TreatmentProbability
Macrolide (azithromycin)49.4%
Oral corticosteroid (prednisolone)27.5%
Inhaled corticosteroid (fluticasone)16.0%
“No treatment”4.8%
NSAID (ibuprofen)2.3%

From: Appendix K, Health Economics

Cover of Cystic Fibrosis
Cystic Fibrosis: Diagnosis and management.
NICE Guideline, No. 78.
National Guideline Alliance (UK).
Copyright © NICE 2017.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.